Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Trump Media and Technology Group Corp (DJT) vs Pfizer Inc (PFE) Price & Performance

Trump Media and Technology Group CorpTrade
Pfizer IncTrade

Price performance (Past 24H)

Key statistics

Trump Media and Technology Group Corp vs Pfizer Inc — how do they compare? Trump Media and Technology Group Corp trades at $8.11 (market cap $2.28B), while Pfizer Inc trades at $28.21 (market cap $158.56B). The key difference: Pfizer Inc is far larger — about 69.5× Trump Media and Technology Group Corp's market cap, and Pfizer Inc pays a 6.18% dividend while Trump Media and Technology Group Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Trump Media and Technology Group Corp for 17 Days and Pfizer Inc for 158 Days on average.

DJTPFE
Market Cap
$2.28B$158.56B
Volume
3,148,37944,138,282
Sector
MediaHealth
52-Week High
$17.07$29.02
52-Week Low
$7.06$23.67
Typical Hold Time
17 Days158 Days
Enterprise Value
$2.35B$210.06B
Dividend Yield
—6.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Trump Media and Technology Group Corp

DJT trades at $8.29, up 0.85% on the day, but technical indicators signal a bearish trend with 17 sell signals versus 7 buy signals. The company reported a net loss of $712.06 million on revenue of $3.68 million in 2025, with a negative net income margin of -28,860.41%. Recent news highlights a proposed merger with TAE Technologies, filed with the SEC on September 30, 2026, which could pivot the company toward fusion energy development.

The outlook remains highly speculative. The merger with TAE offers a potential long-term growth avenue in advanced technology, but severe financial losses, negative profitability ratios, and significant cash burn pose substantial risks. Investor sentiment is mixed, weighed down by the company's weak fundamentals against transformative merger prospects.

Pfizer Inc

Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.

The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DJT

No sentiment data available yet.

PFE
11% Buy89% Sell
Avg holding period · 158 Days

Top news

Latest headlines on both assets

About Trump Media and Technology Group Corp

Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.

Read more on DJT →

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Read more on PFE →